Dr. Gerald Raymond is a clinical geneticist and neurologist at Johns Hopkins where he is also a professor of genetic medicine and neurology. He obtained his MD at the University of Connecticut and was trained in Pediatrics at Johns Hopkins Hospital and Neurology at the Mass. General Hospital. He received additional training in developmental neuropathology at the Universite Catholique de Louvain in Belgium and clinical genetics at the Harvard Program. Dr. Raymond’s research has been at the overlap of genetics and neurology with specific focus on peroxisomal disorders including adrenoleukodystrophy. He has been actively involved in newborn screening for ALD and in developing clinical follow-up programs. He has extensive experience in clinical management of neurogenetic issues including peroxisomal and lysosomal disorders. He presently serves as the Director of the Lysosomal Storage Disease program in the department of Genetic Medicine. Dr. Raymond is rated as an Elite provider by MediFind in the treatment of Adrenoleukodystrophy (ALD). His top areas of expertise are Adrenoleukodystrophy (ALD), CACH Syndrome, Zellweger Syndrome, and Leukodystrophy.

Eric Mallack is a Pediatric Neurologist and a Neurologist in Baltimore, Maryland. Dr. Mallack is rated as an Elite provider by MediFind in the treatment of Adrenoleukodystrophy (ALD). His top areas of expertise are Adrenoleukodystrophy (ALD), CACH Syndrome, Early Infantile Epileptic Encephalopathy, and Leukodystrophy.

Dr. Fatemi received his medical degree from the Medical University of Vienna, Austria in 1999. After graduation, he served as a researcher and lecturer at the Institute for Medical Chemistry in Vienna and at the Department of Pediatrics at the Vienna General Hospital. He then moved to the United States to pursue a postdoctoral fellowship in neurogenetics and neuroimaging at Johns Hopkins University School of Medicine in 2001. During this initial period, Dr. Fatemi collaborated with a team of scientists and developed new imaging methods in patients with leukodystrophies (rare genetic diseases that affect the brain's white matter) and coordinated an internet-2 based imaging network for these diseases. He then left Kennedy Krieger Institute to train in general pediatrics and then completed a child neurology residency at the Massachusetts General Hospital, an affiliate of Harvard Medical School. Dr. Fatemi returned to the Kennedy Krieger Institute in 2008 as faculty. He is a member of the Child Neurology Society, the International Child Neurology Association, the Society for Neuroscience, the American Academy of Neurology and the International Society for Magnetic Resonance in Medicine. He has served as ad hoc reviewer for the Journals Child Development and American Journal of Neuroradiology. Dr. Fatemi is rated as a Distinguished provider by MediFind in the treatment of Adrenoleukodystrophy (ALD). His top areas of expertise are Adrenoleukodystrophy (ALD), CACH Syndrome, Canavan Disease, and Leukodystrophy.

Amena Fine is a Pediatrics provider in Baltimore, Maryland. Dr. Fine is rated as an Advanced provider by MediFind in the treatment of Adrenoleukodystrophy (ALD). Her top areas of expertise are Adrenoleukodystrophy (ALD), CACH Syndrome, HNRNPH2-Related Disorder, and Leukodystrophy.

Dr. Aniket Sidhaye is an assistant professor of medicine and pediatrics at the Johns Hopkins University School of Medicine. His specific clinical interests are cystic fibrosis related endocrine disorders, type 1 diabetes mellitus particularly emerging adults with diabetes, thyroid disorders, metabolic bone disease, and management of hospitalized persons with diabetes. Dr. Sidhaye earned his M.D. from Northwestern University’s Feinberg School of Medicine. He completed his residency at Northwestern University. He performed a research fellowship in endocrinology and metabolism at Northwestern University and also performed fellowships in endocrinology and metabolism at Johns Hopkins. His research interests include CF related diabetes, bone health of CF patients after lung transplant, and the care of emerging adults with type 1 diabetes. In addition, he is a committed educator serving as an advisor in the medical school, co-director for the endocrine course for pre-clinical medical students, and program director for our endocrine fellowship. Dr. Sidhaye is rated as an Experienced provider by MediFind in the treatment of Adrenoleukodystrophy (ALD). His top areas of expertise are Type B Insulin Resistance Syndrome, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Paget's Disease of Bone.

Dr. Mowry became interested in multiple sclerosis (MS) prior to beginning college and first performed MS research as an undergraduate biology major at Georgetown University. As a neurology resident at the University of Pennsylvania, she began her multiple sclerosis clinical research activities in conducting a study of visual dysfunction and quality of life in multiple sclerosis. During her fellowship at UCSF, Dr. Mowry evaluated prognostic factors in multiple sclerosis and examined health-related quality of life in multiple sclerosis, particularly as a marker of disease burden. She also earned a Master’s Degree in Clinical Research at UCSF. Dr. Mowry continued as a member of the faculty there before joining the Johns Hopkins Department of Neurology as an Assistant Professor in July, 2011; she received a joint appointment in Epidemiology in 2013. She was appointed as the inaugural Richard T. and Frances W. Johnson Professor in 2022. Over the past several years, Dr. Mowry has worked primarily to perform epidemiologic investigations of multiple sclerosis (MS) risk and prognostic factors and has evaluated both genetic and environmental contributors. While she has had a major role in several such studies, her most significant work led to the identification of the association of vitamin D status with relapse and brain lesion risk in patients with MS (Annals of Neurology 2010, Annals of Neurology 2012, European Journal of Neurology 2015). She also conducted the first pilot study comparing gut bacterial populations in patients with MS and healthy individuals (Journal of Investigative Medicine 2014). She was recently funded to investigate the impact of vitamin D supplementation on the metabolomics profile in patients with MS compared to healthy controls. She enjoys designing and conducting clinical trials in MS and is the Principal Investigator of the Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) multicenter vitamin D trial (NCT01490502), which is sponsored by the National MS Society and a smaller multicenter pilot study investigating vitamin D pharmacokinetics in MS patients and healthy controls (NCT01667796). She is also the recipient of a Harry Weaver Award from the National MS Society, in which she is investigating the impact of intermittent calorie restriction in MS. Finally, as Director of the MS Experimental Therapeutics Program at Johns Hopkins, she assists colleagues with study design and helps oversee the conduct of MS clinical trials. Dr. Mowry is rated as an Experienced provider by MediFind in the treatment of Adrenoleukodystrophy (ALD). Her top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Optic Neuritis, and Neuromyelitis Optica.

Nancy Braverman is a Medical Genetics specialist and a Pediatrics provider in Baltimore, Maryland. Dr. Braverman is rated as an Experienced provider by MediFind in the treatment of Adrenoleukodystrophy (ALD). Her top areas of expertise are Zellweger Syndrome, Chondrodysplasia Punctata Syndrome, X-Linked Chondrodysplasia Punctata 2, and Acromesomelic Dysplasia.

Suzette Huguenin is a Medical Genetics provider in Baltimore, Maryland. Dr. Huguenin is rated as an Experienced provider by MediFind in the treatment of Adrenoleukodystrophy (ALD). Her top areas of expertise are Zellweger Syndrome and Adrenoleukodystrophy (ALD).

Sakkubai Naidu is a Neurologist in Baltimore, Maryland. Dr. Naidu is rated as an Experienced provider by MediFind in the treatment of Adrenoleukodystrophy (ALD). Her top areas of expertise are Rett Syndrome, Leukodystrophy, CACH Syndrome, and Hypotonia.